Long-term survival in paraneoplastic opsoclonus-myoclonus syndrome associated with small cell lung cancer

Journal of Neuro-Ophthalmology

Volumn 28, Issue 1, 2008, Pages 27-30

  Hassan, Khaled A ^a   Kalemkerian, Gregory P ^a,b   Trobe, Jonathan D ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b C350 Med Inn Building ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; ETOPOSIDE; FLUORODEOXYGLUCOSE; IMMUNOGLOBULIN; METHYLPREDNISOLONE; PREDNISOLONE;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CASE REPORT; CLINICAL FEATURE; DISEASE ASSOCIATION; EYE EXAMINATION; FEMALE; HUMAN; HUMAN TISSUE; LUNG SMALL CELL CANCER; OPSOCLONUS MYOCLONUS SYNDROME; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SURVIVAL TIME;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRAIN; CARCINOMA, SMALL CELL; DISEASE PROGRESSION; FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOSUPPRESSIVE AGENTS; LUNG; LUNG NEOPLASMS; MIDDLE AGED; OPSOCLONUS-MYOCLONUS SYNDROME; PARANEOPLASTIC SYNDROMES, NERVOUS SYSTEM; RADIOTHERAPY; STEROIDS; SURVIVORS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 40949127429     PISSN: 10708022     EISSN: None     Source Type: Journal    
DOI: 10.1097/WNO.0b013e318167550a     Document Type: Article

References (33)

1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2007. CA Cancer J Clin 2007;57:43-66.
2. Simon G, Ginsberg RJ, Ruckdeschel JC. Small-cell lung cancer. Chest Surg Clin North Am 2001;11:165-88.
3. Johnson BE, Jänne PA. Basic treatment considerations using chemotherapy for patients with small cell lung cancer. Hematol Oncol Clin North Am 2004;18:309-22.
4. Onganer PU, Seckl MJ, Djamgoz MB. Neuronal characteristics of small-cell lung cancer. Br J Cancer 2005;93:1197-201.
5. Anderson NE, Rosenblum MK, Graus F, et al. Autoantibodies in paraneoplastic syndromes associated with small cell lung cancer. Neurology 1988;38:1391-8.
6. Dropcho E, Payne R. Paraneoplastic opsoclonus-myoclonus: association with medullary thyroid carcinoma and review of the literature. Arch Neurol 1986;43:410-5.
7. Yang YY, Yin GL, Darnell RB. The neuronal RNA-binding protein Nova-2 is implicated as the autoantigen targeted in POMA patients with dementia. Proc Natl Acad Sci USA 1998;95:13254-9.
8. Buckanovich RJ, Darnell RB. The neuronal RNA binding protein Nova-1 recognizes specific RNA targets in vitro and in vivo. Mol Cell Biol 1997;17:3194-201.
9. Bataller L, Graus F, Saiz A, et al. Clinical outcome in adult onset idiopathic or paraneoplastic opsoclonus-myoclonus. Brain 2001;124:437-43.
10. Pittock SJ, Lucchinetti CF, Lennon VA. Anti-neuronal nuclear autoantibody type 2: paraneoplastic accompaniments. Ann Neurol 2003;53:580-7.
11. Dropcho EJ. Remote neurologic manifestations of cancer. Neurol Clin 2002;20:85-122.
12. Pranzatelli MR, Tate ED, Wheeler A, et al. Screening for autoantibodies in children with opsoclonus-myoclonus-ataxia. Pediatr Neurol 2002;27:384-7.
13. Scholz J, Vieregge P, Ruff C. Paraneoplastic opsoclonus-myoclonus syndrome in metastatic ovarian carcinoma. J Neurol Neurosurg Psych 1994;57:763-4.
14. De Luca S, Terrone C, Crivellaro S, et al. Opsoclonus-myoclonus syndrome as a paraneoplastic manifestation of renal cell carcinoma. A case report and review of the literature. Urol Int 2002;68:206-8.
15. Kay CL, Davies-Jones GA, Singal R, et al. Paraneoplastic opsoclonus-myoclonus in Hodgkin's disease. J Neurol Neurosurg Psychiatry 1993;56:831-2.
16. Kumar A, Lajara-Nanson WA, Neilson RW Jr. Paraneoplastic opsoclonus-myoclonus syndrome: initial presentation of non-Hodgkins lymphoma. J Neuroncol 2005;73:43-5.
17. Jung KY, Youn J, Chung CS. Opsoclonus-myoclonus syndrome in an adult with malignant melanoma. J Neurol 2006;253:942-3.
18. Antunes NL, Khakoo Y, Matthay KK, et al. Antineuronal antibodies in patients with neuroblastoma and paraneoplastic opsoclonus-myoclonus. J. Pediatr Hematol Oncol 2000;22:315-20.
19. Fisher PG, Wechsler DS, Singer HS. Anti-Hu antibody in a neuroblastoma-associated paraneoplastic syndrome. Pediatr Neurol 1994;10:309-12.
20. Dropcho EJ, Kline LB, Riser J, et al. Antineuronal (anti-Ri) antibodies in a patient with steroid-responsive opsoclonus-myoclonus. Neurology 1993;43:207-11.
21. Noetzel MJ, Cawley LP, James VL, et al. Anti-neurofilament protein antibodies in opsoclonus-myoclonus. J Neuroimmunol 1987;15:137-45.
22. Connolly AM, Pestronk A, Mehta S, et al. Serum autoantibodies in childhood opsoclonus-myoclonus syndrome: an analysis of antigenic targets in neural tissues. J Pediatr 1997;130:878-84.
23. Cooper R, Khakoo Y, Matthay KK, et al. Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: histopathologic features-a report fromthe Children's Cancer Group. Med Pediatr Oncol 2001;36:623-9.
24. Gambini C, Conte M, Bernini G, et al. Neuroblastic tumors associated with opsoclonus-myoclonus syndrome: histological, immunohistochemical and molecular features of 15 Italian cases. Virchows Arch 2003;442:555-62.
25. Veneselli E, Conte M, Biancheri R, et al. Effect of steroid and high-dose immunoglobulin therapy on opsoclonus-myoclonus syndrome occurring in neuroblastoma. Med Pediatr Oncol 1998;30:15-7.
26. Yiu VW, Kovithavongs T, McGonigle LF, et al. Plasmapheresis as an effective treatment for opsoclonus-myoclonus syndrome. Pediatr Neurol 2001;24:72-4.
27. Pranzatelli MR, Tate ED, Travelstead AL, et al. Rituximab (anti-CD20) adjunctive therapy for opsoclonus-myoclonus syndrome. J Pediatr Hematol Oncol 2006;28:585-93.
28. Altman AJ, Baehner RL. Favorable prognosis for survival in children with coincident opso-myoclonus and neuroblastoma. Cancer 1976;37:846-52.
29. Korfei M, Fuhlhuber V, Schmidt-Woll T, et al. Functional characterisation of autoantibodies from patients with pediatric opsoclonus-myoclonus syndrome. J Neuroimmunol 2005;170:150-7.
30. Hersh B, Dalmau J, Dangond F, et al. Paraneoplastic opsoclonus-myoclonus associated with anti-Hu antibody. Neurology 1994;44:1754-5.
31. Nitschke M. Hochberg F. Dropcho E. Improvement of paraneoplastic opsoclonus-myoclonus after protein A column therapy. N Engl J Med 1995;332:192.
32. Blaes F, Jauss M, Krauss J, et al. Adult paraneoplastic opsoclonus-myoclonus syndrome associated with antimitochondrial autoantibodies. J Neurol Neurosurg Psychiatry 2003;74:1595-6.
33. Ohara S, Iijima N, Hayashida K, et al. Autopsy case of opsoclonus-myoclonus-ataxia and cerebellar cognitive affective syndrome associated with small cell carcinoma of the lung. Mov Disord 2007;22:1320-4.